Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Aug 4, 2026
Marc Frahm's Stock Ratings
TD Cowen Analyst
Marc Frahm is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
-14.7%
Smart Score
Overall Average Return Percentile
14th
Number of Ratings
28
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/10/2026 | NUVL | Buy Now | Nuvalent | — | — | → $124 | Downgrade | Buy → Hold | Get Alert | |
| 06/01/2026 | CRDF | Buy Now | Cardiff Oncology | $0.93 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 03/23/2026 | TBPH | Buy Now | Theravance Biopharma | $16.87 | -11.09% | $13 → $15 | Maintains | Hold | Get Alert | |
| 03/17/2026 | NKTR | Buy Now | Nektar Therapeutics | $70.25 | — | — | Initiates | → Buy | Get Alert | |
| 01/13/2026 | INCY | Buy Now | Incyte | $119.00 | 7.56% | $101 → $128 | Maintains | Buy | Get Alert | |
| 01/08/2025 | SANA | Buy Now | Sana Biotechnology | $3.23 | — | — | Upgrade | Hold → Buy | Get Alert | |
| 08/06/2024 | TBPH | Buy Now | Theravance Biopharma | $16.87 | -46.65% | $10 → $9 | Maintains | Hold | Get Alert | |
| 05/01/2024 | INCY | Buy Now | Incyte | $119.00 | -32.77% | $88 → $80 | Maintains | Buy | Get Alert | |
| 08/14/2023 | SANA | Buy Now | Sana Biotechnology | $3.23 | — | — | Initiates | → Market Perform | Get Alert | |
| 06/15/2023 | CGEM | Buy Now | Cullinan Oncology | $16.04 | — | — | Initiates | → Outperform | Get Alert | |
| 05/03/2023 | INCY | Buy Now | Incyte | $119.00 | -21.85% | $100 → $93 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | DICE | Buy Now | DICE Therapeutics | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/08/2023 | INCY | Buy Now | Incyte | $119.00 | -15.97% | $95 → $100 | Maintains | Outperform | Get Alert | |
| 01/26/2023 | MGTA | Buy Now | Magenta Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/22/2022 | IMGO | Buy Now | Imago BioSciences | — | — | → $36 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/16/2021 | XLO | Buy Now | Xilio Therapeutics | $9.00 | — | — | Initiates | → Outperform | Get Alert | |
| 08/24/2021 | TBPH | Buy Now | Theravance Biopharma | $16.87 | -17.01% | $42 → $14 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/23/2021 | NUVL | Buy Now | Nuvalent | — | — | — | Initiates | → Outperform | Get Alert | |
| 08/10/2021 | IMGO | Buy Now | Imago BioSciences | — | — | — | Initiates | → Outperform | Get Alert | |
| 07/20/2021 | ELEV | Buy Now | Elevation Oncology | — | — | — | Initiates | → Outperform | Get Alert | |
| 07/06/2021 | JANX | Buy Now | Janux Therapeutics | $15.80 | — | — | Initiates | → Outperform | Get Alert | |
| 06/21/2021 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | — | Initiates | → Outperform | Get Alert | |
| 06/03/2021 | CNST | Buy Now | Constellation | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/02/2021 | ANGN | Buy Now | Angion Biomedica | — | — | — | Initiates | → Outperform | Get Alert | |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | — | — | — | Initiates | → Outperform | Get Alert | |
| 05/13/2020 | TBPH | Buy Now | Theravance Biopharma | $16.87 | 148.96% | → $42 | Initiates | → Outperform | Get Alert | |
| 02/24/2020 | BDTX | Buy Now | Black Diamond Therapeutic | $1.75 | — | — | Initiates | → Outperform | Get Alert | |
| 02/07/2020 | CNST | Buy Now | Constellation | — | — | — | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved